Groups urge FDA to halt launch of Zohydro pain drug
[Reuters] – A coalition of addiction experts, physicians and others is urging U.S. health officials to reverse course and block the launch of a powerful painkiller called Zohydro, expected to hit the market next month. The opioid drug, manufactured by Zo more
View todays social media effects on ZGNX
View the latest stocks trending across Twitter. Click to view dashboard